He has around 16 publications to his credit, out of which the most recent ones are listed below:
- Poonyam, P., Chotivitayatarakorn, P., & Vilaichone, R. K. (2019). High effectiveness of 14-day high-dose PPI-bismuth-containing quadruple therapy with probiotics supplement for Helicobacter pylori eradication: a double blinded-randomized placebo-controlled study. Asian Pacific journal of cancer prevention: APJCP, 20(9), 2859.
- Auttajaroon, J., Vilaichone, R. K., Chotivitayatarakorn, P., & Mahachai, V. (2019). Once?daily rabeprazole, levofloxacin, clarithromycin?MR, and bismuth for Helicobacter pylori eradication: A randomized study of 7 or 14 days (ONCE study). Helicobacter, 24(5), e12615.
- Limprukkasem, T., Chotivitayatarakorn, P., & Vilaichone, R. K. (2019). Mo1307 Clinical Predictors and Survival Rates of Diffuse and Intestinal Type of Gastric Cancer Patients: A 5-Year Longitudinal Study. Gastrointestinal Endoscopy, 89(6), AB482-AB483.
- Aumpan, N., Vilaichone, R. K., Chotivitayatarakorn, P., Pornthisarn, B., Cholprasertsuk, S., Bhanthumkomol, P., ... & Mahachai, V. (2019). High efficacy of rapid urine test for diagnosis of Helicobacter pylori infection in Thai people. Asian Pacific Journal of Cancer Prevention: APJCP, 20(5), 1525.
- Auttajaroon, J., Chotivitayatarakorn, P., Yamaoka, Y., & Vilaichone, R. K. (2019). CYP2C19 genotype, CagA genotype and antibiotic-resistant strain of Helicobacter pylori infection. Asian Pacific journal of cancer prevention: APJCP, 20(4), 1243